Quarterly report pursuant to Section 13 or 15(d)

Share Capital (Details) - Schedule of share capital

v3.21.2
Share Capital (Details) - Schedule of share capital
9 Months Ended
Sep. 30, 2021
USD ($)
shares
Preferred Shares [Member]  
Share Capital (Details) - Schedule of share capital [Line Items]  
Number of shares, balance at beginning | shares
Balance at beginning | $
Number of shares, Issuance of preferred shares | shares 4,000,000 [1]
Issuance of preferred shares | $ $ 4,000 [1]
Number of shares conversion from preferred shares to ordinary shares | shares (3,409,078)
Conversion of preferred shares to ordinary shares | $ $ (3,409)
Number of shares, Redemption of preferred shares | shares (590,922) [2]
Redemption of preferred shares | $ $ (591) [2]
Number of shares, balance at beginning | shares
Balance | $
Ordinary Shares [Member]  
Share Capital (Details) - Schedule of share capital [Line Items]  
Number of shares, balance at beginning | shares 79,302,428
Balance at beginning | $ $ 79,302
Number of shares, Issuance of shares | shares 3,625,954 [3]
Issuance of shares | $ $ 3,626 [3]
Number of shares conversion from preferred shares to ordinary shares | shares 3,805,775
Conversion of preferred shares to ordinary shares | $ $ 3,806
Number of shares, Repurchase of ordinary shares | shares (793,192) [2]
Repurchase of ordinary shares | $ $ (793) [2]
Number of shares, balance at beginning | shares 85,940,965
Balance | $ $ 85,941
[1] On January 8, 2021, the Company issued 4,000,000 of its Series A Convertible Preferred Shares, par value $0.001 per share (“Series A Preferred Shares”), at a purchase price of $1.00 per share and a stated value of $1.10 per share, in a registered direct offering.
[2] On May 27, 2021, the Company redeemed 590,922 Series A Preferred Shares and repurchased 793,192 ordinary shares that were converted following the failure to file the 10-K from the purchaser for aggregate consideration of $1,450,000.
[3] On March 8, 2021, the Company sold 3,625,954 ordinary shares at a price of $1.31 per share, and 2,719,464 five-year warrants to purchase ordinary shares at an exercise price of $1.31 per share, in a registered direct offering.